mRNA Vaccines – Trials Line Up Against Coronavirus

New Technology Attracts Attention

The arrival of SARS-CoV-2 has focused attention on a potential new way of making vaccines – one that promises to be quicker and cheaper than traditional methods and more reactive to novel virus outbreaks, but also one that remains to be validated.

Coronavirus_Blue

More from COVID-19

More from In Vivo